Core Viewpoint - HeMai Co., Ltd. (688032.SH) is currently experiencing a decline in stock price, closing at 103.19 yuan with a drop of 2.98%, indicating a state of share price below its initial public offering (IPO) price [1] Group 1: IPO and Financial Overview - HeMai Co., Ltd. was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 20, 2021, with an IPO price of 557.80 yuan per share and a total issuance of 10 million shares [1] - The total funds raised from the IPO amounted to 5.578 billion yuan, with a net amount of 5.406 billion yuan after deducting issuance costs, which exceeded the original plan by 4.848 billion yuan [1] - The funds raised are intended for projects including the construction of an intelligent manufacturing base, industrialization of energy storage inverters, upgrading of intelligent electrical equipment, and supplementing working capital [1] Group 2: Dividend Announcements - On May 30, 2022, HeMai Co., Ltd. announced a dividend plan of 30 yuan (pre-tax) per 10 shares, along with a bonus issue of 4 shares, with the ex-dividend date set for June 7, 2022 [2] - On June 6, 2023, the company announced a dividend plan of 53 yuan (pre-tax) per 10 shares, with a bonus issue of 4.9 shares, and the ex-dividend date set for June 13, 2023 [2] - A future dividend plan was announced for June 13, 2024, proposing a payout of 36 yuan (pre-tax) per 10 shares, along with a bonus issue of 4.9 shares, with the ex-dividend date set for June 19, 2024 [2]

东方财富证券股份有限公司研究员何玮2021年4月29日发布研报《智飞生物(300122)2020年报点 评：自研代理双轮驱动 自研产品进入收获期》称，维持智飞生物"增持"评级。 (责任编辑：徐自立) 中国经济网北京1月30日讯 智飞生物(300122.SZ)今日股价下跌，截至收盘报17.37元，跌幅 3.45%。 2021年5月17日，智飞生物股价创下历史最高点231.19元。 ...

三一重能首次公开发行股票的发行费用合计14,021.58万元（不包含增值税），其中，保荐及承销 费用11,739.30万元。 本次发行由保荐机构相关子公司跟投，跟投机构为中信证券投资有限公司，获配股数为376.5714 万股，占首次公开发行股票数量的比例为2.00%，获配金额1.12亿元，限售期为24个月。 (责任编辑：徐自立) 中国经济网北京1月30日讯 三一重能(688349.SH)今日股价下跌，截至收盘报26.01元，跌幅 4.59%。该股目前处于破发状态。 三一重能于2022年6月22日在上交所科创板上市，发行新股18828.57万股，发行价格为29.80元/ 股，保荐机构（主承销商）为中信证券，保荐代表人为孙鹏飞、杨成云。 三一重能首次公开发行股票募集资金总额为561,091.43万元，募集资金净额为547,069.86万元。 三一重能实际募资净额比原拟募集资金多243,890.72万元。三一重能于2022年6月17日披露的招股说明 书显示，该公司原拟募集资金303,179.14万元，拟用于"新产品与新技术开发项目""新建大兆瓦风机整 机生产线项目""生产线升级改造项目""风机后市场工艺技术研发项目 ...

中国经济网北京1月30日讯 春立医疗(688236.SH)今日收报23.50元，跌幅6.93%。目前该股处于破 发状态。 春立医疗于2021年12月30日在上交所科创板上市，发行价格为29.81元，发行股份数量3,842.80万 股，保荐机构为华泰联合证券有限责任公司，保荐代表人为张畅、茹涛。 春立医疗上市发行募集资金总额为114,553.87万元，扣除发行费用后募集资金净额为106,712.83万 元，较原拟募集资金净额少93287.17万元。 2021年12月27日，春立医疗发布的招股书显示，公司拟募集资金200,000.00万元，用于骨科植入 物及配套材料综合建设项目、研发中心建设项目、营销网络建设项目、补充流动资金项目。 春立医疗上市发行费用合计7,841.04万元，华泰联合证券有限责任公司获得保荐费用150.00万元、 承销费用6,523.59万元。 (责任编辑：徐自立) ...

Core Viewpoint - The stock price of Dia Shares (301177.SZ) has dropped significantly, closing at 34.90 yuan, reflecting a decline of 12.29% and currently in a state of underperformance [1] Group 1: Company Overview - Dia Shares was listed on the Shenzhen Stock Exchange's ChiNext board on December 15, 2021, with an initial public offering (IPO) of 40.01 million shares at a price of 116.88 yuan per share [1] - The company achieved a total fundraising amount of 4.676 billion yuan from its IPO, with a net amount of 4.444 billion yuan after deducting issuance costs, which was 3.16 billion yuan more than the originally planned net fundraising of 1.284 billion yuan [1] Group 2: Financial Details - The IPO proceeds were intended for several projects, including channel network construction, information system development, a diamond jewelry R&D creative design center, and working capital supplementation [1] - The total issuance costs for the IPO amounted to 233 million yuan, with underwriting and sponsorship fees accounting for 217 million yuan [1] Group 3: Stock Performance - On the first day of trading, Dia Shares reached a peak price of 180 yuan, but has since experienced a downward trend in its stock price [1]

Group 1 - The stock price of Kingsoft Office (688111.SH) decreased by 3.21%, closing at 336.84 yuan [1] - On June 20, 2023, Kingsoft Office's stock price reached an all-time high of 530.50 yuan [2] - A brokerage report published on June 21, 2023, maintained a "buy" rating for Kingsoft Office, highlighting the gradual formation of its AI + office business model and the upgrade of WPS AI product capabilities [2]

爱建证券有限责任公司研究员许亮1月12日发布研报《蓝思科技公司点评：CES2026蓝思科技发布前沿 应用进展》称，维持蓝思科技"买入"评级和盈利预测。 蓝思科技1月12日股价盘中最高达到43.44元，创年内高点。 中国经济网北京1月30日讯蓝思科技（300433）(300433.SZ)今日收报36.35元，跌幅3.17%。 ...

| 股东名称 | 上海共荣投资中心(有限合伙) | | --- | --- | | 减持计划首次披露日期 | 2025年11月28日 | | 减持数量 | 4,146,811股 | | 减持期间 | 2025年12月19日~2026年1月14日 | | 减持方式及对应减持数 | 集中竞价减持,1,852,400 股 | | 물 | 大宗交易减持,2,294,411 股 | | 减持价格区间 | 21.98~23.29元/股 | | 减持息金额 | 94,228,251.08元 | | 减持完成情况 | 已完成 | | 减持比例 | 0. 90% | | 原计划减持比例 | 不超过:0.90% | | 当前持股数量 | 0股 | | 当前持股比例 | 0% | | 股东名称 | 上海共远投资中心(有限合伙) | | --- | --- | | 减持计划首次披露日期 | 2025年11月28日 | | 减持数量 | 2.991,130股 | | 减持期间 | 2025年12月26日~2026年1月14日 | | 减持方式及对应减持数 | 集中竞价减持,921,300 股 | | 를 | 大宗交易减持,2,069, ...

据新浪财经，周志文从2020年11月5日起，第一次减持昭衍新药股份，迄今为止，累计减持公司股 票1411.32万股，累计套现约9.15亿元。 昭衍新药2024年年报显示，昭衍新药实际控制人为冯宇霞、周志文夫妇。 (责任编辑：何潇) 周志文于2025年12月30日披露了减持计划，自减持计划公告之日起15个交易日后的3个月内通过上 海证券交易所以集中竞价或大宗交易的方式减持不超过14,980,000股,不超过其持有股份的20.0466%，不 超过公司当时总股本的1.99873%。2026年1月22日至2026年1月28日，周志文以大宗交易及集中竞价交易 的方式减持公司A股股份14,979,000股，并决定提前终止减持计划。本次减持价格区间为34.78至42.19元/ 股，减持总金额为567,606,657.9元。 | 股东名称 | 周志文 | | --- | --- | | 减持计划首次披露日期 | 2025 年 12 月 30 日 | | 減持数量 | 14,979,000股 | | 减持期间 | 2026年1月22日~2026年1月28日 | | 减持方式及对应减持数 | 集中竞价减持,6.490,000 股 ...

Core Viewpoint - Meidel, a leading supplier of intelligent conveyor systems in China, successfully listed on the Beijing Stock Exchange, with a closing price of 109.50 yuan, marking a significant increase of 161.46% on its first day of trading [1]. Group 1: Company Overview - Meidel specializes in the research, design, manufacturing, and sales of intelligent manufacturing equipment, primarily focusing on modular conveyor systems and industrial components [1]. - The company’s total market capitalization reached 7.897 billion yuan following its listing [1]. Group 2: Shareholder Information - Zhang Yongxin, the chairman and general manager, held 25,900,000 shares before and after the issuance, with a shareholding ratio decreasing from 46.15% to 35.91% [1]. - Zhang is identified as the controlling shareholder and actual controller of the company [1]. Group 3: Financial Performance - Meidel's revenue for 2022, 2023, and 2024 was reported at 1.031 billion yuan, 1.009 billion yuan, and 1.138 billion yuan, respectively, with net profits of 222.5 million yuan, 205 million yuan, and 211 million yuan [3]. - The company expects its revenue for 2025 to be between 1.3 billion and 1.4 billion yuan, representing a year-on-year growth of 14.26% to 23.05% [8]. Group 4: Fundraising and Project Investment - The company raised a total of 670.08 million yuan from its public offering, with a net amount of 608.27 million yuan after deducting issuance costs [2]. - The funds will be allocated to four major projects, including the fourth phase of Meidel's construction project and various R&D initiatives, with a total investment of approximately 794.28 million yuan [3]. Group 5: Cash Flow and Sustainability - The net cash flow from operating activities for 2022, 2023, and 2024 was reported at 224 million yuan, 94 million yuan, and 25 million yuan, respectively, indicating a significant decline in 2024 [5][6]. - The company faces inquiries regarding the sustainability of its operating performance amid declining customer performance and slowed capacity expansion [2].